The increased tracer uptake in the temporal and occipital cortices was consistent with the known distribution of NFTs found at autopsy in AD patients (Braak et al., 2006) and results from tau-PET imaging (Okamura et al., 2014; Marquié et al., 2017; Shimada et al., 2017). This evidence concerns the gene MAPT and Alzheimer disease.